{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:28:44Z","timestamp":1793860124435,"version":"4.6.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019725","name":"Deanship of Scientific Research, Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11553-y","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:05:42Z","timestamp":1777842342000},"page":"8961-8980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The architecture of computational antiviralism: a multi-scale framework from molecular targeting to viral ecosystem engineering"],"prefix":"10.1007","volume":"30","author":[{"given":"Ahmed I.","family":"Foudah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"11553_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2485","author":"E De Clercq","year":"2007","unstructured":"De Clercq E (2007) Three decades of antiviral drugs. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/nrd2485","journal-title":"Nat Rev Drug Discov"},{"key":"11553_CR2","doi-asserted-by":"publisher","DOI":"10.3892\/br.2022.1580","author":"I Diakou","year":"2022","unstructured":"Diakou I, Papakonstantinou E, Papageorgiou L, Pierouli K, Dragoumani K, Spandidos DA, Bacopoulou F, Chrousos GP, Eliopoulos E, Vlachakis D (2022) Novel computational pipelines in antiviral structure-based drug design (review). Biomed Rep. https:\/\/doi.org\/10.3892\/br.2022.1580","journal-title":"Biomed Rep"},{"key":"11553_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70022-5","author":"DH King","year":"1988","unstructured":"King DH (1988) History, pharmacokinetics, and pharmacology of acyclovir. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/S0190-9622(88)70022-5","journal-title":"J Am Acad Dermatol"},{"key":"11553_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-15","author":"E De Clercq","year":"2016","unstructured":"De Clercq E, Li G (2016) Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00102-15","journal-title":"Clin Microbiol Rev"},{"key":"11553_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.115","author":"N Takizawa","year":"2018","unstructured":"Takizawa N, Yamasaki M (2018) Current landscape and future prospects of antiviral drugs derived from microbial products. J Antibiot Tokyo. https:\/\/doi.org\/10.1038\/ja.2017.115","journal-title":"J Antibiot Tokyo"},{"key":"11553_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0178-y","author":"HM Mengist","year":"2020","unstructured":"Mengist HM, Fan X, Jin T (2020) Designing of improved drugs for COVID-19: crystal structure of SARS-CoV-2 main protease Mpro. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-020-0178-y","journal-title":"Signal Transduct Target Ther"},{"key":"11553_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4784","author":"DR Owen","year":"2021","unstructured":"Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre RA, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y (2021) An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Sci. https:\/\/doi.org\/10.1126\/science.abl4784","journal-title":"Sci"},{"key":"11553_CR8","unstructured":"U.S. Food and Drug Administration (FDA), Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. Food and Drug Administration (2021)."},{"key":"11553_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2577-1","author":"L Riva","year":"2020","unstructured":"Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW, Chan JFW, Cao J, Poon VKM, Herbert KM, Cheng K, Nguyen TTH, Rubanov A, Pu Y, Nguyen C, Choi A, Rathnasinghe R, Schotsaert M, Miorin L, Dejosez M, Zwaka TP, Sit KY, Martinez-Sobrido L, Liu WC, White KM, Chapman ME, Lendy EK, Glynne RJ, Albrecht R, Ruppin E, Mesecar AD, Johnson JR, Benner C, Sun R, Schultz PG, Su AI, Garc\u00eda-Sastre A, Chatterjee AK, Yuen KY, Chanda SK (2020) Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2577-1","journal-title":"Nature"},{"key":"11553_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03828-1","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, \u017d\u00eddek A, Bridgland A, Cowie A, Meyer C, Laydon A, Velankar S, Kleywegt GJ, Bateman A, Evans R, Pritzel A, Figurnov M, Ronneberger O, Bates R, Kohl SAA, Potapenko A, Ballard AJ, Romera-Paredes B, Nikolov S, Jain R, Clancy E, Reiman D, Petersen S, Senior AW, Kavukcuoglu K, Birney E, Kohli P, Jumper J, Hassabis D (2021) Highly accurate protein structure prediction for the human proteome. Nature. https:\/\/doi.org\/10.1038\/s41586-021-03828-1","journal-title":"Nature"},{"key":"11553_CR11","doi-asserted-by":"publisher","unstructured":"J.G. McEwen, Nobel Prize in Chemistry 2024, Rev Acad Colomb Cienc Exactas Fis Nat 48 (2024). https:\/\/doi.org\/10.18257\/raccefyn.3108.","DOI":"10.18257\/raccefyn.3108"},{"key":"11553_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0224-x","author":"A Zhavoronkov","year":"2019","unstructured":"Zhavoronkov A, Ivanenkov YA, Aliper A, Veselov MS, Aladinskiy VA, Aladinskaya AV, Terentiev VA, Polykovskiy DA, Kuznetsov MD, Asadulaev A, Volkov Y, Zholus A, Shayakhmetov RR, Zhebrak A, Minaeva LI, Zagribelnyy BA, Lee LH, Soll R, Madge D, Xing L, Guo T, Aspuru-Guzik A (2019) Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-019-0224-x","journal-title":"Nat Biotechnol"},{"key":"11553_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3036","author":"GL Law","year":"2013","unstructured":"Law GL, Korth MJ, Benecke AG, Katze MG (2013) Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat Rev Microbiol. https:\/\/doi.org\/10.1038\/nrmicro3036","journal-title":"Nat Rev Microbiol"},{"key":"11553_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105114","author":"STR Moolamalla","year":"2021","unstructured":"Moolamalla STR, Balasubramanian R, Chauhan R, Priyakumar UD, Vinod PK (2021) Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2021.105114","journal-title":"Microb Pathog"},{"key":"11553_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.idm.2018.09.005","author":"W Garira","year":"2018","unstructured":"Garira W (2018) A primer on multiscale modelling of infectious disease systems. Infect Dis Model. https:\/\/doi.org\/10.1016\/j.idm.2018.09.005","journal-title":"Infect Dis Model"},{"key":"11553_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005991","author":"A Ghaffarizadeh","year":"2018","unstructured":"Ghaffarizadeh A, Heiland R, Friedman SH, Mumenthaler SM, Macklin P (2018) PhysiCell: an open source physics-based cell simulator for 3-D multicellular systems. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1005991","journal-title":"PLoS Comput Biol"},{"key":"11553_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04788-w","author":"CJ Carlson","year":"2022","unstructured":"Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, Olival KJ, Ross N, Bansal S (2022) Climate change increases cross-species viral transmission risk. Nature. https:\/\/doi.org\/10.1038\/s41586-022-04788-w","journal-title":"Nature"},{"key":"11553_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A, Bridgland A, Meyer C, Kohl SAA, Ballard AJ, Cowie A, Romera-Paredes B, Nikolov S, Jain R, Adler J, Back T, Petersen S, Reiman D, Clancy E, Zielinski M, Steinegger M, Pacholska M, Berghammer T, Bodenstein S, Silver D, Vinyals O, Senior AW, Kavukcuoglu K, Kohli P, Hassabis D (2021) Highly accurate protein structure prediction with AlphaFold. Nature. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"key":"11553_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1061","author":"M Varadi","year":"2022","unstructured":"Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A, Z\u00eddek A, Green T, Tunyasuvunakool K, Petersen S, Jumper J, Clancy E, Green R, Vora A, Lutfi M, Figurnov M, Cowie A, Hobbs N, Kohli P, Kleywegt G, Birney E, Hassabis D, Velankar S (2022) AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkab1061","journal-title":"Nucleic Acids Res"},{"key":"11553_CR20","doi-asserted-by":"publisher","unstructured":"K. Verba, M. Gupta, C. Azumaya, M. Moritz, S. Pourmal, A. Diallo, G. Merz, G. Jang, M. Bouhaddou, A. Fossati, A. Brilot, D. Diwanji, E. Hernandez, N. Herrera, H. Kratochvil, V. Lam, F. Li, Y. Li, H. Nguyen, C. Nowotny, T. Owens, J. Peters, A. Rizo, U. Schulze-Gahmen, A. Smith, I. Young, Z. Yu, D. Asarnow, C. Billesb\u00f8lle, M. Campbell, J. Chen, K.-H. Chen, U.S. Chio, M. Dickinson, L. Doan, M. Jin, K. Kim, J. Li, Y.-L. Li, E. Linossi, Y. Liu, M. Lo, J. Lopez, K. Lopez, A. Mancino, F.M. Iii, M. Paul, K. Pawar, A. Pelin, T. Pospiech, C. Puchades, S. Remesh, M. Safari, K. Schaefer, M. Sun, M. Tabios, A. Thwin, E. Titus, R. Trenker, E. Tse, T.K.M. Tsui, F. Feng, K. Zhang, Y. Zhang, J. Zhao, F. Zhou, Y. Zhou, L. Zuliani-Alvarez, D. Agard, Y. Cheng, J. Fraser, N. Jura, T. Kortemme, A. Manglik, D. Southworth, R. Stroud, D. Swaney, N. Krogan, A. Frost, O. Rosenberg, CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes. Res. Sq. (2021). https:\/\/doi.org\/10.21203\/rs.3.rs-515215\/v1.","DOI":"10.21203\/rs.3.rs-515215\/v1"},{"key":"11553_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381270-4.00019-6","author":"A Leaver-Fay","year":"2011","unstructured":"Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith CA, Sheffler W, Davis IW, Cooper S, Treuille A, Mandell DJ, Richter F, Ban YEA, Fleishman SJ, Corn JE, Kim DE, Lyskov S, Berrondo M, Mentzer S, Popovi\u0107 Z, Havranek JJ, Karanicolas J, Das R, Meiler J, Kortemme T, Gray JJ, Kuhlman B, Baker D, Bradley P (2011) Rosetta3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. https:\/\/doi.org\/10.1016\/B978-0-12-381270-4.00019-6","journal-title":"Methods Enzymol"},{"key":"11553_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep00571","author":"A Perdomo-Ortiz","year":"2012","unstructured":"Perdomo-Ortiz A, Dickson N, Drew-Brook M, Rose G, Aspuru-Guzik A (2012) Finding low-energy conformations of lattice protein models by quantum annealing. Sci Rep. https:\/\/doi.org\/10.1038\/srep00571","journal-title":"Sci Rep"},{"key":"11553_CR23","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevApplied.20.014024","author":"P Chandarana","year":"2023","unstructured":"Chandarana P, Hegade NN, Montalban I, Solano E, Chen X (2023) Digitized counterdiabatic quantum algorithm for protein folding. Phys Rev Appl. https:\/\/doi.org\/10.1103\/PhysRevApplied.20.014024","journal-title":"Phys Rev Appl"},{"key":"11553_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00140","author":"T Sztain","year":"2021","unstructured":"Sztain T, Amaro R, McCammon JA (2021) Elucidation of cryptic and allosteric pockets within the SARS-CoV-2 main protease. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.1c00140","journal-title":"J Chem Inf Model"},{"key":"11553_CR25","doi-asserted-by":"publisher","DOI":"10.1063\/1.4733951","author":"CN Nguyen","year":"2012","unstructured":"Nguyen CN, Kurtzman Young T, Gilson MK (2012) Grid inhomogeneous solvation theory: hydration structure and thermodynamics of the miniature receptor cucurbit[7]uril. J Chem Phys. https:\/\/doi.org\/10.1063\/1.4733951","journal-title":"J Chem Phys"},{"key":"11553_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c01223","author":"D DasGupta","year":"2022","unstructured":"DasGupta D, Chan WKB, Carlson HA (2022) Computational identification of possible allosteric sites and modulators of the SARS-CoV-2 main protease. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.1c01223","journal-title":"J Chem Inf Model"},{"key":"11553_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246181","author":"MR Freidel","year":"2021","unstructured":"Freidel MR, Armen RS (2021) Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: identification of an allosteric small-molecule binding site on the Nsp13 helicase. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0246181","journal-title":"PLoS ONE"},{"key":"11553_CR28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00575","author":"D Su\u00e1rez","year":"2020","unstructured":"Su\u00e1rez D, D\u00edaz N (2020) SARS-CoV-2 main protease: a molecular dynamics study. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.0c00575","journal-title":"J Chem Inf Model"},{"key":"11553_CR29","doi-asserted-by":"publisher","DOI":"10.1088\/0256-307X\/38\/1\/018701","author":"HM Ding","year":"2021","unstructured":"Ding HM, Yin YW, Di Ni S, Sheng YJ, Ma YQ (2021) Accurate evaluation on the interactions of SARS-CoV-2 with its receptor ACE2 and antibodies CR3022\/CB6. Chin Phys Lett. https:\/\/doi.org\/10.1088\/0256-307X\/38\/1\/018701","journal-title":"Chin Phys Lett"},{"key":"11553_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010470117","author":"Z Li","year":"2020","unstructured":"Li Z, Li X, Huang YY, Wu Y, Liu R, Zhou L, Lin Y, Wu D, Zhang L, Liu H, Xu X, Yu K, Zhang Y, Cui J, Zhan CG, Wang X, Bin Luo H (2020) Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2010470117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11553_CR31","doi-asserted-by":"publisher","DOI":"10.1039\/d0ra07352k","author":"ST Ngo","year":"2020","unstructured":"Ngo ST, Nguyen HM, Thuy Huong LT, Quan PM, Truong VK, Tung NT, Vu VV (2020) Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations. RSC Adv. https:\/\/doi.org\/10.1039\/d0ra07352k","journal-title":"RSC Adv"},{"key":"11553_CR32","doi-asserted-by":"publisher","DOI":"10.1039\/d0sc02823a","author":"K \u015awiderek","year":"2020","unstructured":"\u015awiderek K, Moliner V (2020) Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 mproby QM\/MM computational methods. Chem Sci. https:\/\/doi.org\/10.1039\/d0sc02823a","journal-title":"Chem Sci"},{"key":"11553_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.checat.2022.03.019","author":"J Aranda","year":"2022","unstructured":"Aranda J, Wiecz\u00f3r M, Terrazas M, Brun-Heath I, Orozco M (2022) Mechanism of reaction of RNA-dependent RNA polymerase from SARS-CoV-2. Chem Catal. https:\/\/doi.org\/10.1016\/j.checat.2022.03.019","journal-title":"Chem Catal"},{"key":"11553_CR34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.0c04198","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhou R (2020) Structural basis of the potential binding mechanism of remdesivir to SARS-CoV-2 RNA-dependent RNA polymerase. J Phys Chem B. https:\/\/doi.org\/10.1021\/acs.jpcb.0c04198","journal-title":"J Phys Chem B"},{"key":"11553_CR35","doi-asserted-by":"publisher","DOI":"10.1063\/1.4941093","author":"O Marsalek","year":"2016","unstructured":"Marsalek O, Markland TE (2016) Ab initio molecular dynamics with nuclear quantum effects at classical cost: ring polymer contraction for density functional theory. J Chem Phys. https:\/\/doi.org\/10.1063\/1.4941093","journal-title":"J Chem Phys"},{"key":"11553_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18709-w","author":"A Douangamath","year":"2020","unstructured":"Douangamath A, Fearon D, Gehrtz P, Krojer T, Lukacik P, Owen CD, Resnick E, Strain-Damerell C, Aimon A, \u00c1br\u00e1nyi-Balogh P, Brand\u00e3o-Neto J, Carbery A, Davison G, Dias A, Downes TD, Dunnett L, Fairhead M, Firth JD, Jones SP, Keeley A, Keser\u00fc GM, Klein HF, Martin MP, Noble MEM, O\u2019Brien P, Powell A, Reddi RN, Skyner R, Snee M, Waring MJ, Wild C, London N, von Delft F, Walsh MA (2020) Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-18709-w","journal-title":"Nat Commun"},{"key":"11553_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-021-00522-2","author":"AT McNutt","year":"2021","unstructured":"McNutt AT, Francoeur P, Aggarwal R, Masuda T, Meli R, Ragoza M, Sunseri J, Koes DR (2021) GNINA 1.0: molecular docking with deep learning. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-021-00522-2","journal-title":"J Cheminform"},{"key":"11553_CR38","unstructured":"Y. Wang, S. Murlidaran, D.A. Pearlman, quantum simulations of SARS-CoV-2 main protease M pro Enable Accurate Scoring of Diverse Ligands, n.d."},{"key":"11553_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167748","author":"L Str\u00f6mich","year":"2022","unstructured":"Str\u00f6mich L, Wu N, Barahona M, Yaliraki SN (2022) Allosteric hotspots in the main protease of SARS-CoV-2. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2022.167748","journal-title":"J Mol Biol"},{"key":"11553_CR40","doi-asserted-by":"crossref","unstructured":"R. Evans, M. O\u2019Neill, A. Pritzel, N. Antropova, A. Senior, T. Green, A. \u017d\u00eddek, R. Bates, S. Blackwell, J. Yim, O. Ronneberger, S. Bodenstein, M. Zielinski, A. Bridgland, A. Potapenko, A. Cowie, K. Tunyasuvunakool, R. Jain, E. Clancy, P. Kohli, J. Jumper, D. Hassabis, Protein complex prediction with AlphaFold-Multimer, BioRxiv (2022).","DOI":"10.1101\/2021.10.04.463034"},{"key":"11553_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-014-9363-3","author":"L Canini","year":"2014","unstructured":"Canini L, Perelson AS (2014) Viral kinetic modeling: state of the art. J Pharmacokinet Pharmacodyn. https:\/\/doi.org\/10.1007\/s10928-014-9363-3","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"11553_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00069-15","author":"MA Kamal","year":"2015","unstructured":"Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CAA, Smith PF, Rayner CR (2015) A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00069-15","journal-title":"Antimicrob Agents Chemother"},{"key":"11553_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfac101","author":"WC Chou","year":"2023","unstructured":"Chou WC, Lin Z (2023) Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling. Toxicol Sci. https:\/\/doi.org\/10.1093\/toxsci\/kfac101","journal-title":"Toxicol Sci"},{"key":"11553_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-018-0503-9","author":"J Shi","year":"2019","unstructured":"Shi J, Zha W (2019) Predicting human pharmacokinetics: physiologically based pharmacokinetic modeling and in silico ADME prediction in early drug discovery. Eur J Drug Metab Pharmacokinet. https:\/\/doi.org\/10.1007\/s13318-018-0503-9","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"11553_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-009-0636-5","author":"VM Khedkar","year":"2010","unstructured":"Khedkar VM, Ambre PK, Verma J, Shaikh MS, Pissurlenkar RRS, Coutinho EC (2010) Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors. J Mol Model. https:\/\/doi.org\/10.1007\/s00894-009-0636-5","journal-title":"J Mol Model"},{"key":"11553_CR46","doi-asserted-by":"publisher","DOI":"10.2174\/157340912803519624","author":"GM Ko","year":"2012","unstructured":"Ko GM, Reddy AS, Garg R, Kumar S, Hadaegh AR (2012) Computational modeling methods for QSAR studies on HIV-1 integrase inhibitors (2005-2010). Curr Comput Aided Drug Des. https:\/\/doi.org\/10.2174\/157340912803519624","journal-title":"Curr Comput Aided Drug Des"},{"key":"11553_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202100190","author":"L John","year":"2022","unstructured":"John L, Soujanya Y, Mahanta HJ, Sastry GN (2022) Chemoinformatics and machine learning approaches for identifying antiviral compounds. Mol Inform. https:\/\/doi.org\/10.1002\/minf.202100190","journal-title":"Mol Inform"},{"key":"11553_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2015.01.008","author":"MH Fatemi","year":"2015","unstructured":"Fatemi MH, Heidari A, Gharaghani S (2015) QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors. J Theor Biol. https:\/\/doi.org\/10.1016\/j.jtbi.2015.01.008","journal-title":"J Theor Biol"},{"key":"11553_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1787-8_12","author":"F Palazzesi","year":"2022","unstructured":"Palazzesi F, Pozzan A (2022) Deep learning applied to ligand-based de novo drug design. Methods Mol Biol. https:\/\/doi.org\/10.1007\/978-1-0716-1787-8_12","journal-title":"Methods Mol Biol"},{"key":"11553_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00732","author":"M Wang","year":"2022","unstructured":"Wang M, Hsieh CY, Wang J, Wang D, Weng G, Shen C, Yao X, Bing Z, Li H, Cao D, Hou T (2022) Relation: a deep generative model for structure-based de novo drug design. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00732","journal-title":"J Med Chem"},{"key":"11553_CR51","unstructured":"C. Vignac, I. Krawczuk, A. Siraudin, B. Wang, V. Cevher, P. Frossard, DiGress: discrete denoising diffusion for graph generation, (2023). http:\/\/arxiv.org\/abs\/2209.14734."},{"key":"11553_CR52","unstructured":"C. Pang, Y. Wang, Y. Jiang, R. Wang, R. Su, L. Wei, Multi-view deep learning based molecule design and structural optimization accelerates the SARS-CoV-2 inhibitor discovery, n.d."},{"key":"11553_CR53","doi-asserted-by":"publisher","unstructured":"T.A. Hopf, A.G. Green, B. Schubert, S. Mersmann, C.P.I. Sch\u00e4rfe, J.B. Ingraham, A. Toth-Petroczy, K. Brock, A.J. Riesselman, P. Palmedo, C. Kang, R. Sheridan, E.J. Draizen, C. Dallago, C. Sander, D.S. Marks, The EVcouplings Python framework for coevolutionary sequence analysis, Bioinformatics 35 (2019). https:\/\/doi.org\/10.1093\/bioinformatics\/bty862.","DOI":"10.1093\/bioinformatics\/bty862"},{"key":"11553_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.11.007","author":"AJ Greaney","year":"2021","unstructured":"Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KHD, Dingens AS, Nargi RS, Sutton RE, Suryadevara N, Rothlauf PW, Liu Z, Whelan SPJ, Carnahan RH, Crowe JE, Bloom JD (2021) Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. https:\/\/doi.org\/10.1016\/j.chom.2020.11.007","journal-title":"Cell Host Microbe"},{"key":"11553_CR55","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41564-025-02030-7","volume":"10","author":"F Jian","year":"2025","unstructured":"Jian F, Wec AZ, Feng L, Yu Y, Wang L, Wang P, Yu L, Wang J, Hou J, Berrueta DM, Lee D, Speidel T, Ma LZ, Kim T, Yisimayi A, Song W, Wang J, Liu L, Yang S, Niu X, Xiao T, An R, Wang Y, Shao F, Wang Y, Pecetta S, Wang X, Walker LM, Cao Y (2025) Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variants. Nat Microbiol 10:2003\u20132017. https:\/\/doi.org\/10.1038\/s41564-025-02030-7","journal-title":"Nat Microbiol"},{"key":"11553_CR56","doi-asserted-by":"publisher","DOI":"10.1039\/d0cs01084g","author":"Y Ma","year":"2021","unstructured":"Ma Y, Frutos-Beltr\u00e1n E, Kang D, Pannecouque C, De Clercq E, Men\u00e9ndez-Arias L, Liu X, Zhan P (2021) Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem Soc Rev. https:\/\/doi.org\/10.1039\/d0cs01084g","journal-title":"Chem Soc Rev"},{"key":"11553_CR57","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00104","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11553_CR58","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkae254","volume":"52","author":"Y Myung","year":"2024","unstructured":"Myung Y, De S\u00e1 AGC, Ascher DB (2024) Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res 52:W469\u2013W475. https:\/\/doi.org\/10.1093\/nar\/gkae254","journal-title":"Nucleic Acids Res"},{"key":"11553_CR59","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2016.0289","author":"C Hadjichrysanthou","year":"2016","unstructured":"Hadjichrysanthou C, Cau\u00ebt E, Lawrence E, Vegvari C, De Wolf F, Anderson RM (2016) Understanding the within-host dynamics of influenza a virus: from theory to clinical implications. J R Soc Interface. https:\/\/doi.org\/10.1098\/rsif.2016.0289","journal-title":"J R Soc Interface"},{"key":"11553_CR60","doi-asserted-by":"publisher","DOI":"10.5599\/admet.628","author":"G Gao","year":"2019","unstructured":"Gao G, Law F, Wong RNS, Mak NK, Yang MSM (2019) A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans. ADMET DMPK. https:\/\/doi.org\/10.5599\/admet.628","journal-title":"ADMET DMPK"},{"key":"11553_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11095-025-03858-8","volume":"42","author":"L Podina","year":"2025","unstructured":"Podina L, Ghodsi A, Kohandel M (2025) Learning chemotherapy drug action via universal physics-informed neural networks. Pharm Res 42:593\u2013612. https:\/\/doi.org\/10.1007\/s11095-025-03858-8","journal-title":"Pharm Res"},{"key":"11553_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109392","author":"N Ahmadi Daryakenari","year":"2025","unstructured":"Ahmadi Daryakenari N, Wang S, Karniadakis G (2025) CMINNs: compartment model informed neural networks\u2014unlocking drug dynamics. Comput Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109392","journal-title":"Comput Biol Med"},{"key":"11553_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab243","author":"P Pei","year":"2021","unstructured":"Pei P, Qin H, Chen J, Wang F, He C, He S, Hong B, Liu K, Qiao R, Fan H, Tong Y, Chen L, Luo SZ (2021) Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab243","journal-title":"Brief Bioinform"},{"key":"11553_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41520","author":"S Rahmati","year":"2025","unstructured":"Rahmati S, Zandi F, Ahmadi K, Adeli A, Rastegarpanah N, Amanlou M, Vaziri B (2025) Computational structure-based design of antiviral peptides as potential protein\u2013protein interaction inhibitors of rabies virus phosphoprotein and human LC8. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41520","journal-title":"Heliyon"},{"key":"11553_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae208","author":"J Guan","year":"2024","unstructured":"Guan J, Yao L, Xie P, Chung CR, Huang Y, Chiang YC, Lee TY (2024) A two-stage computational framework for identifying antiviral peptides and their functional types based on contrastive learning and multi-feature fusion strategy. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae208","journal-title":"Brief Bioinform"},{"key":"11553_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00610-23","author":"X Yang","year":"2023","unstructured":"Yang X, Duan H, Liu X, Zhang X, Pan S, Zhang F, Gao P, Liu B, Yang J, Chi X, Yang W (2023) Broad Sarbecovirus neutralizing antibodies obtained by computational design and synthetic library screening. J Virol. https:\/\/doi.org\/10.1128\/jvi.00610-23","journal-title":"J Virol"},{"key":"11553_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98979-w","author":"Y Kang","year":"2025","unstructured":"Kang Y, Jin K, Pan L (2025) AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-98979-w","journal-title":"Sci Rep"},{"key":"11553_CR68","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827999210111194101","author":"SS Sohrab","year":"2021","unstructured":"Sohrab SS, El-Kafrawy SA, Abbas AT, Bajrai LH, Azhar EI (2021) In Silico prediction and designing of potential siRNAs to be used as antivirals against SARS-CoV-2. Curr Pharm Des. https:\/\/doi.org\/10.2174\/1381612827999210111194101","journal-title":"Curr Pharm Des"},{"key":"11553_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2023.2217400","author":"\u00c9 Houbron","year":"2023","unstructured":"Houbron \u00c9, Mockly S, Rafasse S, Gros N, Muriaux D, Seitz H (2023) Biochemistry-informed design selects potent siRNAs against SARS-CoV-2. RNA Biol. https:\/\/doi.org\/10.1080\/15476286.2023.2217400","journal-title":"RNA Biol"},{"key":"11553_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac144","author":"D Zhang","year":"2022","unstructured":"Zhang D, Tian J, Wang Y, Lu J (2022) Evitar: designing anti-viral RNA therapies against future RNA viruses. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btac144","journal-title":"Bioinformatics"},{"key":"11553_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201909987","author":"CW Coley","year":"2020","unstructured":"Coley CW, Eyke NS, Jensen KF (2020) Autonomous discovery in the chemical sciences Part I: progress. Angew Chem Int Ed. https:\/\/doi.org\/10.1002\/anie.201909987","journal-title":"Angew Chem Int Ed"},{"key":"11553_CR72","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.2c00207","author":"AMK Nambiar","year":"2022","unstructured":"Nambiar AMK, Breen CP, Hart T, Kulesza T, Jamison TF, Jensen KF (2022) Bayesian optimization of computer-proposed multistep synthetic routes on an automated robotic flow platform. ACS Cent Sci. https:\/\/doi.org\/10.1021\/acscentsci.2c00207","journal-title":"ACS Cent Sci"},{"key":"11553_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56788-9","author":"T Wu","year":"2025","unstructured":"Wu T, Kheiri S, Hickman RJ, Tao H, Wu TC, Yang ZB, Ge X, Zhang W, Abolhasani M, Liu K, Aspuru-Guzik A, Kumacheva E (2025) Self-driving lab for the photochemical synthesis of plasmonic nanoparticles with targeted structural and optical properties. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-56788-9","journal-title":"Nat Commun"},{"key":"11553_CR74","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1021\/acs.chemrev.4c00055","volume":"124","author":"G Tom","year":"2024","unstructured":"Tom G, Schmid SP, Baird SG, Cao Y, Darvish K, Hao H, Lo S, Pablo-Garc\u00eda S, Rajaonson EM, Skreta M, Yoshikawa N, Corapi S, Akkoc GD, Strieth-Kalthoff F, Seifrid M, Aspuru-Guzik A (2024) Self-driving laboratories for chemistry and materials science. Chem Rev 124:9633\u20139732. https:\/\/doi.org\/10.1021\/acs.chemrev.4c00055","journal-title":"Chem Rev"},{"key":"11553_CR75","doi-asserted-by":"publisher","DOI":"10.1098\/rsfs.2021.0018","author":"AP Bhati","year":"2021","unstructured":"Bhati AP, Wan S, Alf\u00e8 D, Clyde AR, Bode M, Tan L, Titov M, Merzky A, Turilli M, Jha S, Highfield RR, Rocchia W, Scafuri N, Succi S, Kranzlm\u00fcller D, Mathias G, Wifling D, Donon Y, Di Meglio A, Vallecorsa S, Ma H, Trifan A, Ramanathan A, Brettin T, Partin A, Xia F, Duan X, Stevens R, Coveney PV (2021) Pandemic drugs at pandemic speed: infrastructure for accelerating COVID-19 drug discovery with hybrid machine learning- and physics-based simulations on high-performance computers. Interface Focus. https:\/\/doi.org\/10.1098\/rsfs.2021.0018","journal-title":"Interface Focus"},{"key":"11553_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12201-9","author":"K Jha","year":"2022","unstructured":"Jha K, Saha S, Singh H (2022) Prediction of protein\u2013protein interaction using graph neural networks. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-12201-9","journal-title":"Sci Rep"},{"key":"11553_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac759","author":"M R\u00e9au","year":"2023","unstructured":"R\u00e9au M, Renaud N, Xue LC, Bonvin AMJJ (2023) DeepRank-GNN: a graph neural network framework to learn patterns in protein\u2013protein interfaces. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btac759","journal-title":"Bioinformatics"},{"key":"11553_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30546-7","author":"L Zeng","year":"2022","unstructured":"Zeng L, Liu Y, Nguyenla XH, Abbott TR, Han M, Zhu Y, Chemparathy A, Lin X, Chen X, Wang H, Rane DA, Spatz JM, Jain S, Rustagi A, Pinsky B, Zepeda AE, Kadina AP, Walker JA, Holden K, Temperton N, Cochran JR, Barron AE, Connolly MD, Blish CA, Lewis DB, Stanley SA, La Russa MF, Qi LS (2022) Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-30546-7","journal-title":"Nat Commun"},{"key":"11553_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw103","author":"MG Ammari","year":"2016","unstructured":"Ammari MG, Gresham CR, McCarthy FM, Nanduri B (2016) HPIDB 2.0: a curated database for host-pathogen interactions. Database (Oxford). https:\/\/doi.org\/10.1093\/database\/baw103","journal-title":"Database (Oxford)"},{"key":"11553_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1121","author":"T Guirimand","year":"2015","unstructured":"Guirimand T, Delmotte S, Navratil V (2015) VirHostNet 2.0: surfing on the web of virus\/host molecular interactions data. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gku1121","journal-title":"Nucleic Acids Res"},{"key":"11553_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O\u2019Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, H\u00fcttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu YF, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O\u2019Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d\u2019Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, Garc\u00eda-Sastre A, Shokat KM, Shoichet BK, Krogan NJ (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"11553_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe9403","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, Jureka AS, Obernier K, Guo JZ, Batra J, Kaake RM, Weckstein AR, Owens TW, Gupta M, Pourmal S, Titus EW, Cakir M, Soucheray M, McGregor M, Cakir Z, Jang G, O\u2019Meara MJ, Tummino TA, Zhang Z, Foussard H, Rojc A, Zhou Y, Kuchenov D, H\u00fcttenhain R, Xu J, Eckhardt M, Swaney DL, Fabius JM, Ummadi M, Tutuncuoglu B, Rathore U, Modak M, Haas P, Haas KM, Naing ZZC, Pulido EH, Shi Y, Barrio-Hernandez I, Memon D, Petsalaki E, Dunham A, Marrero MC, Burke D, Koh C, Vallet T, Silvas JA, Azumaya CM, Billesb\u00f8lle C, Brilot AF, Campbell MG, Diallo A, Dickinson MS, Diwanji D, Herrera N, Hoppe N, Kratochvil HT, Liu Y, Merz GE, Moritz M, Nguyen HC, Nowotny C, Puchades C, Rizo AN, Schulze-Gahmen U, Smith AM, Sun M, Young ID, Zhao J, Asarnow D, Biel J, Bowen A, Braxton JR, Chen J, Chio CM, Chio US, Deshpande I, Doan L, Faust B, Flores S, Jin M, Kim K, Lam VL, Li F, Li J, Li YL, Li Y, Liu X, Lo M, Lopez KE, Melo AA, Moss FR, Nguyen P, Paulino J, Pawar KI, Peters JK, Pospiech TH, Safari M, Sangwan S, Schaefer K, Thomas PV, Thwin AC, Trenker R, Tse E, Tsui TKM, Wang F, Whitis N, Yu Z, Zhang K, Zhang Y, Zhou F, Saltzberg D, Hodder AJ, Shun-Shion AS, Williams DM, White KM, Rosales R, Kehrer T, Miorin L, Moreno E, Patel AH, Rihn S, Khalid MM, Vallejo-Gracia A, Fozouni P, Simoneau CR, Roth TL, Wu D, Karim MA, Ghoussaini M, Dunham I, Berardi F, Weigang S, Chazal M, Park J, Logue J, McGrath M, Weston S, Haupt R, Hastie CJ, Elliott M, Brown F, Burness KA, Reid E, Dorward M, Johnson C, Wilkinson SG, Geyer A, Giesel DM, Baillie C, Raggett S, Leech H, Toth R, Goodman N, Keough KC, Lind AL, Klesh RJ, Hemphill KR, Carlson-Stevermer J, Oki J, Holden K, Maures T, Pollard KS, Sali A, Agard DA, Cheng Y, Fraser JS, Frost A, Jura N, Kortemme T, Manglik A, Southworth DR, Stroud RM, Alessi DR, Davies P, Frieman MB, Ideker T, Abate C, Jouvenet N, Kochs G, Shoichet B, Ott M, Palmarini M, Shokat KM, Garc\u00eda-Sastre A, Rassen JA, Grosse R, Rosenberg OS, Verba KA, Basler CF, Vignuzzi M, Peden AA, Beltrao P, Krogan NJ (2020) Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Sci. https:\/\/doi.org\/10.1126\/science.abe9403","journal-title":"Sci"},{"key":"11553_CR83","doi-asserted-by":"publisher","unstructured":"Y. Zhou, Y. Liu, S. Gupta, M.I. Paramo, Y. Hou, C. Mao, Y. Luo, J. Judd, S. Wierbowski, M. Bertolotti, M. Nerkar, L. Jehi, N. Drayman, V. Nicolaescu, H. Gula, S. Tay, G. Randall, P. Wang, J.T. Lis, C. Feschotte, S.C. Erzurum, F. Cheng, H. Yu, A comprehensive SARS-CoV-2\u2013human protein\u2013protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat. Biotechnol. 41 (2023). https:\/\/doi.org\/10.1038\/s41587-022-01474-0.","DOI":"10.1038\/s41587-022-01474-0"},{"key":"11553_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952192","author":"M Alegr\u00eda-Arcos","year":"2022","unstructured":"Alegr\u00eda-Arcos M, Barbosa T, Sep\u00falveda F, Combariza G, Gonz\u00e1lez J, Gil C, Mart\u00ednez A, Ram\u00edrez D (2022) Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.952192","journal-title":"Front Pharmacol"},{"key":"11553_CR85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024302118","author":"WD Jang","year":"2021","unstructured":"Jang WD, Jeon S, Kim S, Lee SY (2021) Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.2024302118","journal-title":"Proc Natl Acad Sci USA"},{"key":"11553_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-020-00285-9","author":"TH Pham","year":"2021","unstructured":"Pham TH, Qiu Y, Zeng J, Xie L, Zhang P (2021) A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing. Nat Mach Intell. https:\/\/doi.org\/10.1038\/s42256-020-00285-9","journal-title":"Nat Mach Intell"},{"key":"11553_CR87","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202110260","author":"K Cheng","year":"2021","unstructured":"Cheng K, Martin\u2010Sancho L, Pal LR, Pu Y, Riva L, Yin X, Sinha S, Nair NU, Chanda SK, Ruppin E (2021) Genome\u2010scale metabolic modeling reveals SARS\u2010CoV\u20102\u2010induced metabolic changes and antiviral targets. Mol Syst Biol. https:\/\/doi.org\/10.15252\/msb.202110260","journal-title":"Mol Syst Biol"},{"key":"11553_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08148-y","author":"A Renz","year":"2025","unstructured":"Renz A, Hohner M, Jami R, Breitenbach M, Josephs-Spaulding J, D\u00fcrrwald J, Best L, Duli\u00e8re V, Mialon C, Bader SM, Marinos G, Leonidou N, Cabreiro F, Pellegrini M, Doerflinger M, Rosa-Calatrava M, Pizzorno A, Dr\u00e4ger A, Schindler M, Kaleta C (2025) Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-025-08148-y","journal-title":"Commun Biol"},{"key":"11553_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap7885","author":"M Popova","year":"2018","unstructured":"Popova M, Isayev O, Tropsha A (2018) Deep reinforcement learning for de novo drug design. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aap7885","journal-title":"Sci Adv"},{"key":"11553_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-022-00733-0","author":"M Korshunova","year":"2022","unstructured":"Korshunova M, Huang N, Capuzzi S, Radchenko DS, Savych O, Moroz YS, Wells CI, Willson TM, Tropsha A, Isayev O (2022) Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds. Commun Chem. https:\/\/doi.org\/10.1038\/s42004-022-00733-0","journal-title":"Commun Chem"},{"key":"11553_CR91","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00325","author":"N St\u00e5hl","year":"2019","unstructured":"St\u00e5hl N, Falkman G, Karlsson A, Mathiason G, Bostr\u00f6m J (2019) Deep reinforcement learning for multiparameter optimization in de novo drug design. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.9b00325","journal-title":"J Chem Inf Model"},{"key":"11553_CR92","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1021\/acs.jcim.4c00895","volume":"64","author":"A Bou","year":"2024","unstructured":"Bou A, Thomas M, Dittert S, Navarro C, Majewski M, Wang Y, Patel S, Tresadern G, Ahmad M, Moens V, Sherman W, Sciabola S, De Fabritiis G (2024) ACEGEN: reinforcement learning of generative chemical agents for drug discovery. J Chem Inf Model 64:5900\u20135911. https:\/\/doi.org\/10.1021\/acs.jcim.4c00895","journal-title":"J Chem Inf Model"},{"key":"11553_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.45","author":"RK Plowright","year":"2017","unstructured":"Plowright RK, Parrish CR, McCallum H, Hudson PJ, Ko AI, Graham AL, Lloyd-Smith JO (2017) Pathways to zoonotic spillover. Nat Rev Microbiol. https:\/\/doi.org\/10.1038\/nrmicro.2017.45","journal-title":"Nat Rev Microbiol"},{"key":"11553_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07896-2","author":"PS Pandit","year":"2018","unstructured":"Pandit PS, Doyle MM, Smart KM, Young CCW, Drape GW, Johnson CK (2018) Predicting wildlife reservoirs and global vulnerability to zoonotic Flaviviruses. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-07896-2","journal-title":"Nat Commun"},{"key":"11553_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/nature22975","author":"KJ Olival","year":"2017","unstructured":"Olival KJ, Hosseini PR, Zambrana-Torrelio C, Ross N, Bogich TL, Daszak P (2017) Host and viral traits predict zoonotic spillover from mammals. Nature. https:\/\/doi.org\/10.1038\/nature22975","journal-title":"Nature"},{"key":"11553_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.012","author":"TN Starr","year":"2020","unstructured":"Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC, King NP, Veesler D, Bloom JD (2020) Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.08.012","journal-title":"Cell"},{"key":"11553_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9302","author":"TN Starr","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD (2021) Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Sci (1979). https:\/\/doi.org\/10.1126\/science.abf9302","journal-title":"Sci (1979)"},{"key":"11553_CR98","doi-asserted-by":"publisher","unstructured":"B. Dadonaite, J. Brown, T.E. McMahon, A.G. Farrell, M.D. Figgins, D. Asarnow, C. Stewart, J. Lee, J. Logue, T. Bedford, B. Murrell, H.Y. Chu, D. Veesler, J.D. Bloom, Spike deep mutational scanning helps predict success of SARS-CoV-2 clades, Nature 631 (2024). https:\/\/doi.org\/10.1038\/s41586-024-07636-1.","DOI":"10.1038\/s41586-024-07636-1"},{"key":"11553_CR99","doi-asserted-by":"publisher","unstructured":"B. Hie, E.D. Zhong, B. Berger, B. Bryson, Learning the language of viral evolution and escape, Science (1979). 371 (2021). https:\/\/doi.org\/10.1126\/science.abd7331.","DOI":"10.1126\/science.abd7331"},{"key":"11553_CR100","doi-asserted-by":"publisher","unstructured":"J.M. Taft, C.R. Weber, B. Gao, R.A. Ehling, J. Han, L. Frei, S.W. Metcalfe, M.D. Overath, A. Yermanos, W. Kelton, S.T. Reddy, Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain, Cell 185 (2022). https:\/\/doi.org\/10.1016\/j.cell.2022.08.024.","DOI":"10.1016\/j.cell.2022.08.024"},{"key":"11553_CR101","doi-asserted-by":"publisher","unstructured":"F. Obermeyer, M. Jankowiak, N. Barkas, S.F. Schaffner, J.D. Pyle, L. Yurkovetskiy, M. Bosso, D.J. Park, M. Babadi, B.L. MacInnis, J. Luban, P.C. Sabeti, J.E. Lemieux, Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness, Science (1979). 376 (2022). https:\/\/doi.org\/10.1126\/science.abm1208.","DOI":"10.1126\/science.abm1208"},{"key":"11553_CR102","doi-asserted-by":"publisher","unstructured":"M. \u0141uksza, M. L\u00e4ssig, A predictive fitness model for influenza, Nature 507 (2014). https:\/\/doi.org\/10.1038\/nature13087.","DOI":"10.1038\/nature13087"},{"key":"11553_CR103","doi-asserted-by":"publisher","unstructured":"R.A. Neher, C.A. Russell, B.I. Shraiman, Predicting evolution from the shape of genealogical trees, Elife 3 (2014). https:\/\/doi.org\/10.7554\/eLife.03568.","DOI":"10.7554\/eLife.03568"},{"key":"11553_CR104","doi-asserted-by":"publisher","unstructured":"J. Huddleston, J.R. Barnes, T. Rowe, X. Xu, R. Kondor, D.E. Wentworth, L. Whittaker, B. Ermetal, R.S. Daniels, J.W. McCauley, S.I. Fujisaki, K. Nakamura, N. Kishida, S. Watanabe, H. Hasegawa, I. Barr, K. Subbarao, P. Barrat-Charlaix, R.A. Neher, T. Bedford, Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A\/H3N2 evolution, Elife 9 (2020). https:\/\/doi.org\/10.7554\/ELIFE.60067.","DOI":"10.7554\/ELIFE.60067"},{"key":"11553_CR105","doi-asserted-by":"publisher","unstructured":"A.N. Matthew, F. Leidner, G.J. Lockbaum, M. Henes, J. Zephyr, S. Hou, D.N. Rao, J. Timm, L.N. Rusere, D.A. Ragland, J.L. Paulsen, K. Prachanronarong, D.I. Soumana, E.A. Nalivaika, N. Kurt Yilmaz, A. Ali, C.A. Schiffer, drug design strategies to avoid resistance in direct-acting antivirals and beyond, Chem. Rev. 121 (2021). https:\/\/doi.org\/10.1021\/acs.chemrev.0c00648.","DOI":"10.1021\/acs.chemrev.0c00648"},{"key":"11553_CR106","doi-asserted-by":"publisher","unstructured":"M.R. Trusheim, A.A. Shrier, Z. Antonijevic, R.A. Beckman, R.K. Campbell, C. Chen, K.T. Flaherty, J. Loewy, D. Lacombe, S. Madhavan, H.P. Selker, L.J. Esserman, PIPELINEs: creating comparable clinical knowledge efficiently by linking trial platforms, Clin. Pharmacol. Ther. 100 (2016). https:\/\/doi.org\/10.1002\/cpt.514.","DOI":"10.1002\/cpt.514"},{"key":"11553_CR107","doi-asserted-by":"publisher","unstructured":"N. Guerin, A. Feichtner, E. Stefan, T. Kaserer, B.R. Donald, Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures, Cell Syst. 13 (2022). https:\/\/doi.org\/10.1016\/j.cels.2022.09.003.","DOI":"10.1016\/j.cels.2022.09.003"},{"key":"11553_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap9072","author":"SA Babayan","year":"2018","unstructured":"Babayan SA, Orton RJ, Streicker DG (2018) Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes. Sci (1979). https:\/\/doi.org\/10.1126\/science.aap9072","journal-title":"Sci (1979)"},{"key":"11553_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05506-2","author":"P Eby","year":"2023","unstructured":"Eby P, Peel AJ, Hoegh A, Madden W, Giles JR, Hudson PJ, Plowright RK (2023) Pathogen spillover driven by rapid changes in bat ecology. Nature. https:\/\/doi.org\/10.1038\/s41586-022-05506-2","journal-title":"Nature"},{"key":"11553_CR110","doi-asserted-by":"publisher","unstructured":"R.K. Plowright, A.N. Ahmed, T. Coulson, T.W. Crowther, I. Ejotre, C.L. Faust, W.F. Frick, P.J. Hudson, T. Kingston, P.O. Nameer, M.T. O\u2019Mara, A.J. Peel, H. Possingham, O. Razgour, D.A.M. Reeder, M. Ruiz-Aravena, N.B. Simmons, P.N. Srinivas, G.M. Tabor, I. Tanshi, I.G. Thompson, A.T. Vanak, N.M. Vora, C.E. Willison, A.T.H. Keeley, Ecological countermeasures to prevent pathogen spillover and subsequent pandemics, Nat. Commun. 15 (2024). https:\/\/doi.org\/10.1038\/s41467-024-46151-9.","DOI":"10.1038\/s41467-024-46151-9"},{"key":"11553_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3002268","author":"CE Brook","year":"2023","unstructured":"Brook CE, Rozins C, Guth S, Boots M (2023) Reservoir host immunology and life history shape virulence evolution in zoonotic viruses. Plos Biol. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3002268","journal-title":"Plos Biol"},{"key":"11553_CR112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002324118","author":"ZL Grange","year":"2021","unstructured":"Grange ZL, Goldstein T, Johnson CK, Anthony S, Gilardi K, Daszak P, Olival KJ, O\u2019Rourke T, Murray S, Olson SH, Togami E, Vidal G, Mazet JAK (2021) Ranking the risk of animal-to-human spillover for newly discovered viruses. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2002324118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11553_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4245","author":"K Kyrou","year":"2018","unstructured":"Kyrou K, Hammond AM, Galizi R, Kranjc N, Burt A, Beaghton AK, Nolan T, Crisanti A (2018) A CRISPR\u2013Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4245","journal-title":"Nat Biotechnol"},{"key":"11553_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53065-z","author":"PA Hancock","year":"2024","unstructured":"Hancock PA, North A, Leach AW, Winskill P, Ghani AC, Godfray HCJ, Burt A, Mumford JD (2024) The potential of gene drives in malaria vector species to control malaria in African environments. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-53065-z","journal-title":"Nat Commun"},{"key":"11553_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19426-0","author":"A Adolfi","year":"2020","unstructured":"Adolfi A, Gantz VM, Jasinskiene N, Lee HF, Hwang K, Terradas G, Bulger EA, Ramaiah A, Bennett JB, Emerson JJ, Marshall JM, Bier E, James AA (2020) Efficient population modification gene-drive rescue system in the malaria mosquito Anopheles stephensi. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-19426-0","journal-title":"Nat Commun"},{"key":"11553_CR116","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41586-025-09283-6","volume":"645","author":"Z Li","year":"2025","unstructured":"Li Z, Dong Y, You L, Corder RM, Arzobal J, Yeun A, Yang L, Marshall JM, Dimopoulos G, Bier E (2025) Driving a protective allele of the mosquito FREP1 gene to combat malaria. Nature 645:746\u2013754. https:\/\/doi.org\/10.1038\/s41586-025-09283-6","journal-title":"Nature"},{"key":"11553_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf3370","author":"R Laubenbacher","year":"2021","unstructured":"Laubenbacher R, Sluka JP, Glazier JA (2021) Using digital twins in viral infection. Sci (1979). https:\/\/doi.org\/10.1126\/science.abf3370","journal-title":"Sci (1979)"},{"key":"11553_CR118","doi-asserted-by":"publisher","unstructured":"A.M. Ekstr\u00f6m, O.P. Ottersen, Digital twin for pandemic monitoring and prevention: Urgent need for agreements for global data sharing, Proc. Natl. Acad. Sci. U. S. A. 120 (2023). https:\/\/doi.org\/10.1073\/pnas.2311969120.","DOI":"10.1073\/pnas.2311969120"},{"key":"11553_CR119","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s42256-024-00895-7","volume":"6","author":"A Rodr\u00edguez","year":"2024","unstructured":"Rodr\u00edguez A, Kamarthi H, Agarwal P, Ho J, Patel M, Sapre S, Prakash BA (2024) Machine learning for data-centric epidemic forecasting. Nat Mach Intell 6:1122\u20131131. https:\/\/doi.org\/10.1038\/s42256-024-00895-7","journal-title":"Nat Mach Intell"},{"key":"11553_CR120","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s43588-025-00798-6","volume":"5","author":"H Du","year":"2025","unstructured":"Du H, Zhao Y, Zhao J, Xu S, Lin X, Chen Y, Gardner LM, Yang H\u2018 (2025) Advancing real-time infectious disease forecasting using large language models,. Nat Comput Sci 5:467\u2013480. https:\/\/doi.org\/10.1038\/s43588-025-00798-6","journal-title":"Nat Comput Sci"},{"key":"11553_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00610-z","author":"R Laubenbacher","year":"2022","unstructured":"Laubenbacher R, Niarakis A, Helikar T, An G, Shapiro B, Malik-Sheriff RS, Sego TJ, Knapp A, Macklin P, Glazier JA (2022) Building digital twins of the human immune system: toward a roadmap,. NPJ Digit Med. https:\/\/doi.org\/10.1038\/s41746-022-00610-z","journal-title":"NPJ Digit Med"},{"key":"11553_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s44160-022-00231-0","author":"M Abolhasani","year":"2023","unstructured":"Abolhasani M, Kumacheva E (2023) The rise of self-driving labs in chemical and materials sciences,. Nat Synth. https:\/\/doi.org\/10.1038\/s44160-022-00231-0","journal-title":"Nat Synth"},{"key":"11553_CR123","doi-asserted-by":"publisher","unstructured":"N.J. Szymanski, B. Rendy, Y. Fei, R.E. Kumar, T. He, D. Milsted, M.J. McDermott, M. Gallant, E.D. Cubuk, A. Merchant, H. Kim, A. Jain, C.J. Bartel, K. Persson, Y. Zeng, G. Ceder, An autonomous laboratory for the accelerated synthesis of novel materials, Nature 624 (2023). https:\/\/doi.org\/10.1038\/s41586-023-06734-w.","DOI":"10.1038\/s41586-023-06734-w"},{"key":"11553_CR124","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi1407","author":"BA Koscher","year":"2023","unstructured":"Koscher BA, Canty RB, McDonald MA, Greenman KP, McGill CJ, Bilodeau CL, Jin W, Wu H, Vermeire FH, Jin B, Hart T, Kulesza T, Li SC, Jaakkola TS, Barzilay R, G\u00f3mez-Bombarelli R, Green WH, Jensen KF (2023) Autonomous, multiproperty-driven molecular discovery: from predictions to measurements and back,. Sci. https:\/\/doi.org\/10.1126\/science.adi1407","journal-title":"Sci"},{"key":"11553_CR125","doi-asserted-by":"publisher","unstructured":"J. Born, C. Baldassari, D. Grabocka, A. Cardinale, O. Schilter, A. Castrogiovanni, A. Leonov, F. Skogh, J. Singh, Y. Xiong, J. Evans, T. Fleming, T. Laino, M. Manica, toward fully autonomous closed-loop molecular discovery\u2014a case study on JAK targets, (2026). https:\/\/doi.org\/10.26434\/chemrxiv-2026-q7xdt.","DOI":"10.26434\/chemrxiv-2026-q7xdt"},{"key":"11553_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.11.004","author":"S Chaturvedi","year":"2021","unstructured":"Chaturvedi S, Vasen G, Pablo M, Chen X, Beutler N, Kumar A, Tanner E, Illouz S, Rahgoshay D, Burnett J, Holguin L, Chen PY, Ndjamen B, Ott M, Rodick R, Rogers T, Smith DM, Weinberger LS (2021) Identification of a therapeutic interfering particle\u2014a single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance,. Cell. https:\/\/doi.org\/10.1016\/j.cell.2021.11.004","journal-title":"Cell"},{"key":"11553_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22341-7","author":"VV Rezelj","year":"2021","unstructured":"Rezelj VV, Carrau L, Merwaiss F, Levi LI, Erazo D, Tran QD, Henrion-Lacritick A, Gausson V, Suzuki Y, Shengjuler D, Meyer B, Vallet T, Weger-Lucarelli J, Bernhauerov\u00e1 V, Titievsky A, Sharov V, Pietropaoli S, Diaz-Salinas MA, Legros V, Pardigon N, Barba-Spaeth G, Brodsky L, Saleh MC, Vignuzzi M (2021) Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts,. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-22341-7","journal-title":"Nat Commun"},{"key":"11553_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.020","author":"TR Abbott","year":"2020","unstructured":"Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis DB, Qi LS (2020) Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza,. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.04.020","journal-title":"Cell"},{"key":"11553_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00822-w","author":"EL Blanchard","year":"2021","unstructured":"Blanchard EL, Vanover D, Bawage SS, Tiwari PM, Rotolo L, Beyersdorf J, Peck HE, Bruno NC, Hincapie R, Michel F, Murray J, Sadhwani H, Vanderheyden B, Finn MG, Brinton MA, Lafontaine ER, Hogan RJ, Zurla C, Santangelo PJ (2021) Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents,. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-00822-w","journal-title":"Nat Biotechnol"},{"key":"11553_CR130","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap9026","author":"C Emerson","year":"2017","unstructured":"Emerson C, James S, Littler K, Randazzo F (2017) Principles for gene drive research. Sci. https:\/\/doi.org\/10.1126\/science.aap9026","journal-title":"Sci"},{"key":"11553_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01591-w","author":"RI Taitingfong","year":"2023","unstructured":"Taitingfong RI, Triplett C, V\u00e1squez VN, Rajagopalan RM, Raban R, Roberts A, Terradas G, Baumgartner B, Emerson C, Gould F, Okumu F, Schairer CE, Bossin HC, Buchman L, Campbell KJ, Clark A, Delborne J, Esvelt K, Fisher J, Friedman RM, Gronvall G, Gurfield N, Heitman E, Kofler N, Kuiken T, Kuzma J, Manrique-Saide P, Marshall JM, Montague M, Morrison AC, Opesen CC, Phelan R, Piaggio A, Quemada H, Rudenko L, Sawadogo N, Smith R, Tuten H, Ullah A, Vorsino A, Windbichler N, Akbari OS, Long K, Lavery JV, Evans SW, Tountas K, Bloss CS (2023) Exploring the value of a global gene drive project registry. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-022-01591-w","journal-title":"Nat Biotechnol"},{"key":"11553_CR132","doi-asserted-by":"publisher","DOI":"10.1007\/s11248-023-00335-z","author":"SL James","year":"2023","unstructured":"James SL, Dass B, Quemada H (2023) Regulatory and policy considerations for the implementation of gene drive-modified mosquitoes to prevent malaria transmission. Transgenic Res. https:\/\/doi.org\/10.1007\/s11248-023-00335-z","journal-title":"Transgenic Res"},{"key":"11553_CR133","doi-asserted-by":"publisher","unstructured":"J.B. Connolly, A. Burt, G. Christophides, A. Diabate, T. Habtewold, P.A. Hancock, A.A. James, J.K. Kayondo, D.W. Lwetoijera, A. Manjurano, A.R. McKemey, M.R. Santos, N. Windbichler, F. Randazzo, Considerations for first field trials of low-threshold gene drive for malaria vector control, Malar. J. 23 (2024). https:\/\/doi.org\/10.1186\/s12936-024-04952-9.","DOI":"10.1186\/s12936-024-04952-9"},{"key":"11553_CR134","doi-asserted-by":"publisher","unstructured":"B.D. Trump, S. Galaitsi, E. Appleton, D.A. Bleijs, M. Florin, J.D. Gollihar, R.A. Hamilton, T. Kuiken, F. Lentzos, R. Mampuys, M. Merad, T. Novossiolova, K. Oye, E. Perkins, N. Garcia\u2010Reyero, C. Rhodes, I. Linkov. (2020) Building biosecurity for synthetic biology, Mol. Syst. Biol. https:\/\/doi.org\/10.15252\/msb.20209723.","DOI":"10.15252\/msb.20209723"},{"key":"11553_CR135","doi-asserted-by":"publisher","DOI":"10.1057\/s41599-024-03976-5","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang T, Wei X, Xiao Z, Zhang W (2024) Reducing potential dual-use risks in synthetic biology laboratory research: a dynamic model of analysis. Humanit Soc Sci Commun. https:\/\/doi.org\/10.1057\/s41599-024-03976-5","journal-title":"Humanit Soc Sci Commun"},{"key":"11553_CR136","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14136","author":"S Maghsoudi","year":"2022","unstructured":"Maghsoudi S, Taghavi Shahraki B, Rameh F, Nazarabi M, Fatahi Y, Akhavan O, Rabiee M, Mostafavi E, Lima EC, Saeb MR, Rabiee N (2022) A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discovery. Chem Biol Drug Des. https:\/\/doi.org\/10.1111\/cbdd.14136","journal-title":"Chem Biol Drug Des"},{"key":"11553_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100026","author":"NG Bajad","year":"2021","unstructured":"Bajad NG, Rayala S, Gutti G, Sharma A, Singh M, Kumar A, Singh SK (2021) Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2. Curr Res Pharmacol Drug Discov. https:\/\/doi.org\/10.1016\/j.crphar.2021.100026","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"11553_CR138","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4562974","author":"OH Onyango","year":"2023","unstructured":"Onyango OH (2023) In silico models for anti-COVID-19 drug discovery: a systematic review. Adv Pharmacol Pharm Sci. https:\/\/doi.org\/10.1155\/2023\/4562974","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"11553_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-025-01583-2","author":"T Xu","year":"2025","unstructured":"Xu T, Xu M, Zhang Q, Chen CZ, Zheng W, Huang R (2025) Leveraging viral genome sequences and machine learning models for identification of potentially selective antiviral agents. Commun Chem. https:\/\/doi.org\/10.1038\/s42004-025-01583-2","journal-title":"Commun Chem"},{"key":"11553_CR140","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01372","author":"T Xu","year":"2022","unstructured":"Xu T, Xu M, Zhu W, Chen CZ, Zhang Q, Zheng W, Huang R (2022) Efficient identification of Anti-SARS-CoV-2 compounds using chemical structure- and biological activity-based modeling. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01372","journal-title":"J Med Chem"},{"key":"11553_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4712","author":"EA Fink","year":"2023","unstructured":"Fink EA, Bardine C, Gahbauer S, Singh I, Detomasi TC, White K, Gu S, Wan X, Chen J, Ary B, Glenn I, O\u2019Connell J, O\u2019Donnell H, Fajtov\u00e1 P, Lyu J, Vigneron S, Young NJ, Kondratov IS, Alisoltani A, Simons LM, Lorenzo-Redondo R, Ozer EA, Hultquist JF, O\u2019Donoghue AJ, Moroz YS, Taunton J, Renslo AR, Irwin JJ, Garc\u00eda-Sastre A, Shoichet BK, Craik CS (2023) Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors. Protein Sci. https:\/\/doi.org\/10.1002\/pro.4712","journal-title":"Protein Sci"},{"key":"11553_CR142","doi-asserted-by":"publisher","unstructured":"V. Ivanov, K. Lohachova, Y. Kolesnik, A. Zakharov, L. Yevsieieva, A. Kyrychenko, T. Langer, S.M. Kovalenko, O.N. Kalugin. 2023 recent advances in computational drug discovery for therapy against coronavirus SARS-COV-2. ScienceRise: Pharmaceutical Science. https:\/\/doi.org\/10.15587\/2519-4852.2023.290318.","DOI":"10.15587\/2519-4852.2023.290318"},{"key":"11553_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1182465","author":"M Elkashlan","year":"2023","unstructured":"Elkashlan M, Ahmad RM, Hajar M, Al Jasmi F, Corchado JM, Nasarudin NA, Mohamad MS (2023) A review of SARS-CoV-2 drug repurposing: databases and machine learning models. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1182465","journal-title":"Front Pharmacol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11553-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:02:17Z","timestamp":1793858537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11553-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":143,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11553"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11553-y","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}